|Last Price$69.03||Day Change (%)0.98%|
|Open Price$69.07||Day Change ($)0.67|
|Day Range68.97–69.20||52-Week Range57.00–77.92|
As of Fri 7/22/2016 5:02:00 PM | USD
Charlotte's NBA All-Star 'shame' is a monument to stupidity
OFG Bancorp Reports 2Q16 Results
Global Colocation Solutions Provider CyrusOne Completes New Data Hall at Phoenix Data Center Campus
ORIX USA Acquires Boston Financial Investment Management LP
Omega Announces Pricing of $700 Million Senior Notes Offering
IHS and Markit Announce Exchange Offer and Consent Solicitation for IHS Notes
Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.
Regulatory issues that we believe have little impact on Novo Nordisk's long-run prospects have finally helped shares of the leading insulin maker go on sale.
Relevant questions (and answers) for investors as they continue their research into bankruptcy and pension issues.